Duration and exclusiveness of breastfeeding and school-age lung function and asthma

Evelien R van Meel1, Mandy de Jong1, Niels J Elbert2

  • 1The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; Division of Respiratory Medicine and Allergology, Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Insights

Shorter breastfeeding duration and non-exclusive practices were linked to reduced lung function in school-aged children, but not asthma. These findings highlight the importance of breastfeeding for respiratory health beyond early childhood.

Area of Science:

  • Pediatric respiratory health
  • Epidemiology of childhood diseases
  • Public health and nutrition

Background:

  • Breastfeeding is known to reduce early childhood asthma risk.
  • The long-term impact of breastfeeding on respiratory health in later childhood remains unclear.

Purpose of the Study:

  • To investigate the association between breastfeeding (any, duration, exclusivity) and lung function/asthma in school-aged children.
  • To determine if respiratory infections or atopic status influence these associations.

Main Methods:

  • A population-based prospective cohort study of 4,464 children.
  • Breastfeeding data collected via questionnaires from birth to 1 year.
  • Lung function (spirometry) and asthma assessed at age 10 using questionnaires and regression models.

Main Results:

  • Shorter breastfeeding duration correlated with lower forced expiratory volume in 1 second (FEV1).
  • Breastfeeding for 2-4 months or non-exclusive breastfeeding at 4 months was linked to reduced forced vital capacity (FVC).
  • No significant association was found with asthma, and results were consistent across subgroups.

Conclusions:

  • Shorter duration and non-exclusivity of breastfeeding are associated with diminished lung function (FEV1 and FVC) in school-aged children.
  • Breastfeeding's protective effect on asthma risk does not appear to extend to later childhood based on this study.
  • Findings underscore the lasting impact of breastfeeding on respiratory mechanics into later childhood.
Abstract

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.0K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
65.1K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K